Regulation of cellular response to cisplatin-induced DNA damage and DNA repair in cells overexpressing p185(erbB-2) is dependent on the ras signaling pathway

Oncogene

Volumn 14, Issue 15, 1997, Pages 1827-1835

  Yen, Lily ^a   Zeng Rong, Nie ^a   You, Xiao Li ^a   Richard, Stéphane ^a   Langton Webster, Beatrice C ^b   Alaoui Jamali, Moulay A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b BAYER AG   (Germany)

Author keywords

DNA repair, ras signaling pathway; Drug resistance; P185(erbB 2); TAb 250 antibody; Tyrosine kinase inhibitors

Indexed keywords

CISPLATIN; HERBIMYCIN A; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; HUMAN; MOUSE; NONHUMAN; ONCOGENE C ERB; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030927191     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201019     Document Type: Article

References (58)

1. Ariza RR, Keyse MS, Moggs GJ and Wood DR. (1996). Nucleic Acids Res., 24, 433 - 440.
2. Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD and Stewart SJ. (1994). Cancer Res., 54, 3758 - 3765.
3. Bacus SS, Yarden Y, Oren M, Chin DM, Lyass L, Zelnik CR, Kazarov A, Toyofuku W, Gray-Bablin J, Beerli RR, Hynes NE, Nikiforov M, Haffner R, Gudkov A and Keyomarsi K. (1996). Oncogene, 12, 2535 - 2547.
4. Baselga J, Norton L, Masui H, Pandiclla A, Coplan K, Miller WH Jr and Mendelsohn J. (1993). J. Natl. Cancer Inst., 85, 1327 - 1333.
5. Benz C, Scott G, Sarup J, Johnson R, Tripathy D, Coronado E, Shepard H and Osborne C. (1993). Breast Cancer Res. Treat., 24, 85 - 95.
6. Blenis J. (1993). Proc. Natl. Acad. Sci. USA, 90, 5889.
7. Carty MP, Zernik-Kobak M, McGrath S and Dixon K. (1994). EMBO J., 13, 2114-2123.
8. Chaney SG and Sancar A. (1996). J. Natl. Cancer Inst., 88, 1346 - 1360.
9. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M and Davis RJ. (1994). Cell, 76, 1025 - 1037.
10. Di Fore PP, Pierce JH, Kraus MH, Segatto O, King CR and Aaronson SA. (1987). Science, 237, 178 - 182.
11. Dickstein B, Wosikowski K and Bates S. (1995). Mol. Cell. Endocrinol., 110, 205 - 211.
12. Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A and Greene MI. (1994). Oncogene, 9, 2109 - 2123.
13. Drebin JA, Link VC, Stern DF, Weinberg RA and Greene MI. (1985). Cell, 41, 695 - 706.
14. Drebin JA, Link VC, Weinberg RA and Green MI. (1986). Proc. Natl. Acad. Sci. USA, 83, 9129 - 9133.
15. Earp HS. (1995). Breast Cancer Res. Treat., 35, 115 - 132.
16. Eastman A. (1990). Cancer Cells, 2, 275.
17. Feig LA and Cooper GM. (1988). Mol. Cell. Biol., 8, 3235 - 3243.
18. Gately DP, Sharma A, Christen RD and Howell SB. (1996). Br. J. Cancer, 73, 18 - 23.
19. Hancock MC, Langton BC, Chan T, Toy P, Monahan JJ, Mischak RP and Shawver LK. (1991). Cancer Res., 51, 4575 - 4580.
20. Hartwell LH and Kastan MB. (1994). Science, 266, 1821 - 1828.
21. Hoeijmakers JHJ, Egly J-M and Vermeulen W. (1996). Current Opinion in Genetics & Development, 6, 26 - 33.
22. Jallal B, Schlesinger J and Ullrich A. (1992). J. Biol. Chem., 267, 4357 - 4363.
23. Johnson RT, Collins ARS, Squires S, Mullinger AM, Elliott GC, Downes CS and Rasko I. (1987). J. Cell Sci., 6, 263 - 288.
24. Joneson T, White MA. Wigler MH and Bar-Sagi D. (1996). Science, 271, 810 - 812.
25. Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin J, Seger R, Hynes NE and Yarden Y. (1996). EMBO J., 15, 254 - 264.
26. Katsumata M, Okudaira T, Samanta A, Clark PD, Drebin AJ, Jolicoeur P and Greene IM. (1995). Nature Med., 1, 644 - 648.
27. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Tourney Land Robinson RA. (1990). Cancer Res., 50, 5184 - 5191.
28. Kharbanda S, Ren R, Pandey P, Shafman TD, Feller SM, Weichselbaum RR and Kufe DW. (1995). Nature, 376, 785 - 788.
29. Kumar R, Mandai M, Lipton A, Harvey H and Thompson CB. (1996). Clin. Cancer Res., 2, 1215 - 1219.
30. Kuzumaki T, Matsuda A, Ito K and Ishikawa K. (1996). Biochem. Biophys. Acta, 1310, 185 - 192.
31. Liu Y, Martindale JL, Gorospe M and Holbrook NJ. (1996). Cancer Res., 56, 31 - 35.
32. Lock RB and Ross WE. (1990). Cancer Res., 50, 3761 - 3766.
33. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ. (1951). J. Biol. Chem., 193, 265 - 275.
34. Miller P, Schnur CR, Barbacci E, Moyer PM and Moyer DJ. (1994a). Biochem. Biophys. Res. Comm., 201, 1313 - 1319.
35. Miller P, DiOrio C, Moyer M, Schnur CR, Bruskin A, Cullen W and Moyer DJ. (1994b). Cancer Res., 54, 2724 - 2730.
36. Muller WJ, Sinn E, Pattwengale PK, Wallace R and Leder P. (1988). Cell, 54, 105 - 115.
37. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, Cirrincione CT, Budman DR, Wood WC, Barcos M and Henderson IC. (1994). N. Engl. J. Med., 330, 1260 - 1266.
38. Nishikawa K, Rosenblum MG, Newman RA, Pandita TK, Hittelman WN and Donato NJ. (1992). Cancer Res., 52, 4758 - 4765.
39. Paterson J, Yen L, You XL, Zeng-Rong N and Alaoui-Jamali MA. (1996). Proc. Amer. Cancer Res., 37, 363.
40. Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB and Slamon DJ. (1994). Oncogene, 9, 1829 - 1838.
41. Sancar A. (1994). Science, 226, 1954 - 1956.
42. Satoh T, Endo M, Nakafuku M, Akiyama T, Yamamoto T and Kaziro Y. (1990). Proc. Natl. Acad. Sci. USA, 87, 7926 - 7929.
43. Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao XY, Fang K and Roth JA. (1989). Cancer Res., 49, 4968 - 4971.
44. Shearer MC, Kim HH, Kratz DA and Koland JG. (1996). FASEB J., 10, A998.
45. Shi D, He G, Cao S, Pan W, Zhang H-Z, Yu D and Hung M-C. (1992). Mol. Carcinogen., 5, 213 - 218.
46. Sistonen L, Holtta E, Lehvaslaiho H, Lehtola L and Alitalo K. (1989). J. Cell Biol., 109, 1911 - 1919.
47. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177 - 181.
48. Smith ML, Chem I-T, Zhan Q, Bae I, Chen C-Y, Gilmer TM, Kastan MB, O'Connor PM and Fornace AJ Jr. (1994). Science, 266, 1376 - 1380.
49. Sun H, Tonks NK and Bar-Sagi D. (1994). Science, 266, 285 - 288.
50. Tobin CJ, Bradley SM, Bargmann CI and Weinberg RA. (1982). Nature, 300, 143 - 149.
51. Tyrrell MR. (1996). BioEssays, 18, 139 - 148.
52. Vichi P and Tritton TR. (1991). Cancer Res., 52, 4135 - 4138.
53. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene MI, Williams WV, Cohen JA and Kern JA. (1990). Cancer Res., 50, 421 - 425.
54. Wood RD, Biggerstaff M and Shivji MKK. (1995). Methods: A Companion to Methods in Enzymology, 7, 163 - 175.
55. Yen L, Woo A, Christopoulopoulos G, Batist G, Panasci L, Roy R, Mitra S and Alaoui-Jamali MA. (1995). Mutation Res., 337, 179 - 189.
56. Zanke BW, Boudreau K, Rubie E, Winnett E, Tibbies LA, Zon L, Kyriakis J, Liu F-F and Woodgett JR. (1996). Curr. Biol., 6, 606 - 613.
57. Zeng-Rong N, Paterson J, Alpert L, Tsao M-B, Viallet J and Alaoui-Jamali MA. (1995). Cancer Res., 55, 4760 - 4764.
58. Zhang L, Chang CJ, Bacus SS and Hung MC. (1995). Cancer Res., 55, 3890 - 3896.